Home › High Blood Pressure › Kansas
High Blood Pressure clinical trials in Kansas
11 studies for High Blood Pressure are looking for participants at sites in Kansas.
Cities in Kansas
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- AMR El Dorado, El Dorado
- Cotton O'Neil Diabetes & Endocrinology Center, Topeka
- Tekton Research - Wichita, Wichita
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07064473A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Cotton O'Neil Clinical Research Center, Topeka
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07794579A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Hutchinson
- Research Site, Kansas City
- Research Site, Wichita
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06742723BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
- University of Kansas Medical Center, Kansas City
- Cardiovascular Research Institute of Kansas, Wichita
- West Houston Area Clinical Trial Consultants (Wichita, KS), Wichita
Recruiting
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06059638Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Hutchinson
- Clinical Trial Site, Kansas City
- Clinical Trial Site, Topeka
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07181109Global Paradise System US Post Approval Study
- Ascension via Christi St. Francis, Wichita
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT06297291An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
- Alliance for Multispecialty Research, Wichita
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 30, 2026 · NCT07543120A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- Alliance for Multispecialty Research, Wichita
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Jul 30, 2026 · NCT07610278Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
- Vanda Investigative Site, El Dorado
- Vanda Investigative Site, Wichita
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Feb 27, 2026 · NCT07090161Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
- University of Kansas Medical Center, Kansas City
RecruitingPhase 1/2
Ages 35 to 65 · All sexes · Updated Jun 8, 2025 · NCT04715022Reversing Glucose and Lipid-mediated Vascular Dysfunction
- University of Kansas Medical Center, Kansas City
RecruitingEarly phase 1Healthy volunteers welcome
Ages 18 to 79 · All sexes · Updated Jun 5, 2025 · NCT04832009From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.